The purpose of this study is to test the safety of a novel gene viral vector treatment for
adults with cocaine use disorder-sustained remission. This gene regulates an enzyme (cocaine
hydrolase) that breaks down cocaine into inactive substances, thereby decreasing the
pleasurable feeling this drug usually provides.